This clinical trials will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study and are being conducted by JSS Medical Research.
The development comes after the CDSCO approved an adaptive phase 2 and phase 3 trial of Sputnik V in the country, for which Dr. Reddy is the trial and distribution partner in India.
Sputnik V is currently undergoing phase 3 clinical trials in Russia and the proposed number of subjects is 40,000.
According to the statement, the company has isolated all data centre services as a 'preventive action'.
The Hyderabad-based drug maker said in a press release that this will bea multi-center and randomised controlled study, which willinclude safety and immunogenicity study.
The Hyderabad-based pharmaceutical firm had on October 13 reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phase 2 and 3 human clinical trials.
The development comes less than a month after the Russian government announced its partnership with Dr Reddy’s Laboratories for mass vaccinations by the year-end.
The Hyderabad-based pharmaceutical company had applied to the DCGI late last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine.
The Indian pharma giant has collaborated with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V as well as its distribution.
Meanwhile, another Kozhikode-based laboratory — R-Cell Diagnostics & Research Centre —has filed a complaint against Arma Laboratories with the Valanchery police.
With Coronavirus spreading its tentacles far and wide, a few private hospitals and laboratories in Salem district are allegedly cashing in on the scare of the people.
Scientist and entrepreneur Dr A Velumani started Thyrocare in 1995, using a business model in a focused biochemistry back end laboratory.
Dr Reddy's Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life.
Dr AV Rama Rao, founder of AVRA Pharmaceuticals, said: “The API, if it is imported from China, costs close to $2,000 per kg, which is about Rs 1.25 lakh.
It added that there was a compelling need for indigenous ventilators to mitigate the acute shortage of ventilators.